A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors
I-Mab Biopharma US Limited
I-Mab Biopharma US Limited
Hoffmann-La Roche
Massachusetts General Hospital
Hoffmann-La Roche
Abramson Cancer Center at Penn Medicine